Physician

Charles F. Leinberry, M.D.

According to 2025 Medicare claims, Charles Leinberry, M.D. (NPI: 1073563078) practices hand surgery in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is ROTHMAN ORTHOPAEDICS OF NEW JERSEY, LLC (NPI: 1215978630; TIN: 223700669) and primary practice location at 08234-5598.

Leinberry's data goes back to 2015 and runs through 2024. For example, in 2021, this provider had 385 traditional Medicare patients, billed 1,053 HCPCS/CPT codes, and received $73,622 in Medicare payments. 2024 Part D data shows 19 prescription claims totaling $76 in drug costs. DME data shows 65 claims. Open Payments data shows 9 records totaling $277,538. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,486 to $76. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $757 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$78K$156K2015 Medicare payment: $110,141 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $120,153 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $143,432 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $156,209 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $132,669 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $109,862 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $73,622 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154401,484$110,141
20165381,940$120,153
20176182,071$143,432
20186442,216$156,209
20196001,998$132,669
20205161,675$109,862
20213851,053$73,622
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$743$1.5K2015 Drug cost: $1,486 (USD; Tot_Drug_Cst)2016 Drug cost: $1,267 (USD; Tot_Drug_Cst)2017 Drug cost: $872 (USD; Tot_Drug_Cst)2018 Drug cost: $613 (USD; Tot_Drug_Cst)2019 Drug cost: $371 (USD; Tot_Drug_Cst)2020 Drug cost: $532 (USD; Tot_Drug_Cst)2021 Drug cost: $300 (USD; Tot_Drug_Cst)2022 Drug cost: $67 (USD; Tot_Drug_Cst)2023 Drug cost: $104 (USD; Tot_Drug_Cst)2024 Drug cost: $76 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015111183$1,486
2016115179$1,267
2017118175$872
20188296$613
20193443$371
20203139$532
20211726$300
2022N/R17$67
2023N/R19$104
2024N/R19$76

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $9,850 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $20,737 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $20,276 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $19,138 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $23,886 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $15,084 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $10,750 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20157576$9,850
2016126141$20,737
2017122124$20,276
2018129131$19,138
2019135137$23,886
20208890$15,084
20216465$10,750
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$277,538Zimmer Biomet Holdings, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles F. Leinberry, M.D.?

Tedicare shows public-source Medicare data for Charles F. Leinberry, M.D. (NPI 1073563078), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles F. Leinberry, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles F. Leinberry, M.D.?

Charles F. Leinberry, M.D. is linked to ROTHMAN ORTHOPAEDICS OF NEW JERSEY, LLC (billing NPI 1215978630) in the available physician profile data.

Does Charles F. Leinberry, M.D. have Open Payments data?

Charles F. Leinberry, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.